Trending Topic

2 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

From advances in targeted therapies to the integration of AI and steps towards precision medicine, 2024 brought many exciting developments in the field. With 2025 now unfolding, many of these are likely to continue gaining momentum and potentially redefine patient care. In this latest edition of touchREVIEWS in RMD, we’re excited to present a collection […]

Christian Vestergaard: Biologics for Paediatric Skin Diseases

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Nov 2nd 2021

Touch Medical Media coverage of data presented at EADV 2021:

It was a pleasure to meet Dr Christian Vestergaard (Aarhus University Hospital, Aarhus, Denmark) to discuss the use of biologics in the treatment of paediatric skin diseases.

His presentation entitled ‘The use of biological drugs for skin diseases in children’ was presented at the EADV 30th Congress, 29 Sep – 2 Oct 2021.

Questions

  1. What has been the impact of biological drugs in the treatment of skin diseases? (0:15)
  2. What are the challenges of developing biological treatments in paediatric dermatology? (1:10)
  3. What factors should be considered when prescribing biological treatments for children? (2:02)
  4. What other treatments are in the pipeline? (3:19)

Disclosures: Christian Vestergaard has received honoraria, served on advisory boards and received funding from Novartis, LEO Pharma, AbbVie, Pfizer, MSD and Sanofi.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Gina Furnival.

Filmed in coverage of the EADV’s 30th Congress, 29 Sep – 2 Oct 2021.

This content was developed by Touch Medical Media and is not affiliated with the  European Academy of Dermatology & Venereology  (EADV) or the congress. 

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup